MBrace Therapeutics

📍 San Diego, United States🗓 Founded 2020👥 15 employees💰 Last funded Apr 2023
Biotechnology Research🌐 mbracetrx.com
Website LinkedIn
MBrace Therapeutics is a privately-held biopharmaceutical company devoted to improving the lives of cancer patients through the development of antibody-drug conjugates (ADCs) against novel oncology targets. MBrace is supported by a world-class investor syndicate, including TPG, Avidity Partners, Cowen Healthcare Investments, Venrock and Alta Partners.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in MBrace Therapeutics?
MBrace Therapeutics has 1 investors on record on gritt.io, 1 mid-stage.
When did MBrace Therapeutics last raise funding?
The most recent investment in MBrace Therapeutics recorded on gritt.io was in April 2023.
When was MBrace Therapeutics founded?
MBrace Therapeutics was founded in 2020.
What industry is MBrace Therapeutics in?
MBrace Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is MBrace Therapeutics based?
MBrace Therapeutics is headquartered in San Diego, United States.